BACKGROUND: The rapid diagnostics tests for SARS-CoV-2 antigen vary in their sensitivities, and moreover, genomic mutations may further affect the performance of the assays. We aimed to evaluate the analytical performance of an automated antigen assay and compare its sensitivity in Delta- and Omicron-variant positive clinical samples. MATERIAL AND METHODS: The analytical performance of an automated mariPOC SARS-CoV-2 antigen test was evaluated on a population of community-dwelling subjects with mild respiratory symptoms or being asymptomatic investigated by the RT-qPCR Allplex™ SARS-CoV-2 assay. The sensitivity and specificity of the antigen test were evaluated on prospective 621 nasopharyngeal swabs along with oropharyngeal swabs. The sensitivity regarding variants determined by the Allplex™ SARS-CoV-2 Variant assays was analysed in additional, retrospective 158 Delta and 59 Omicron samples. RESULTS: The overall sensitivity of the antigen test in prospective samples was 77.9% (113/145; 95% confidence interval [CI] 70.3-84.4) with the specificity of 99.8% (95% CI 98.8-100). Regarding the variant, the sensitivity was higher in Omicron-variant samples, 93.2% (55/59; 95% CI 83.5-98.1), compared to Delta-variant samples, 71.5% (113/158; 95% CI 63.8-78.4; p = .001). CONCLUSION: In community-dwelling subjects with mild respiratory symptoms or being asymptomatic, the automated mariPOC SARS-CoV-2 antigen test showed high sensitivity over 98.0% in subgroup samples with cycle threshold (Ct) values < 25. Regarding the variant, the antigen test sensitivity was higher in the Omicron-variant samples compared to the Delta-variant samples. The analytical performance of the antigen test can differ between the SARS-CoV-2 variants, and a re-evaluation should be performed for new circulating lineages.

Department of Medical Microbiology 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Zobrazit více v PubMed

Centre for Health Protection of the Hong Kong Special Administrative Region Government CHP closely monitors cluster of pneumonia cases on Mainland. Dec 31, 2019. https://www.info.gov.hk/gia/general/201912/31/P2019123100667.htm

Cohen J. American Association for the Advancement of Science; Washington, DC: Jan 11, 2020. Chinese researchers reveal draft genome of virus implicated in Wuhan pneumonia outbreak. https://www.sciencemag.org/news/2020/01/chinese-researchers-reveal-draft-genome-virus-implicated-wuhan-pneumonia-outbreak

COVID‐19 National Preparedness Collaborators . Pandemic preparedness and COVID‐19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021. Lancet. 2022;S0140‐6736(22)00172‐6. doi: 10.1016/S0140-6736(22)00172-6 PubMed DOI PMC

Scheiblauer H, Filomena A, Nitsche A, et al. Comparative sensitivity evaluation for 122 CE‐marked rapid diagnostic tests for SARS‐CoV‐2 antigen, Germany, September 2020 to April 2021. Euro Surveill. 2021;26(44):2100441. doi: 10.2807/1560-7917.ES.2021.26.44.2100441 PubMed DOI PMC

Dinnes J, Deeks JJ, Berhane S, et al. Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection. Cochrane Database Syst Rev. 2021;3(3):CD013705. doi: 10.1002/14651858.CD013705.pub2 PubMed DOI PMC

EU health preparedness: a common list of COVID‐19 rapid antigen tests; a common standardised set of data to be included in COVID‐19 test result certificates; and a common list of COVID‐19 laboratory based antigenic assays. Available at: https://ec.europa.eu/health/system/files/2022-03/covid-19_rat_common-list_en_0.pdf

Lauring AS, Hodcroft EB. Genetic variants of SARS‐CoV‐2—what do they mean? Jama. 2021;325(6):529‐531. doi: 10.1001/jama.2020.27124 PubMed DOI

World Health Organization . Tracking SARS‐CoV‐2 Variants. World Health Organization; Available at: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/

Ma W, Yang J, Fu H, et al. Genomic perspectives on the emerging SARS‐CoV‐2 omicron variant. Genomics Proteomics Bioinformatics. 2022;S1672‐0229(22)00002‐X. doi: 10.1016/j.gpb.2022.01.001 PubMed DOI PMC

Bekliz M, Perez‐Rodriguez F, Puhach O, et al. Sensitivity of SARS‐CoV‐2 antigen‐detecting rapid tests for Omicron variant. medRxiv. 2021.12.18.21268018. doi: 10.1101/2021.12.18.21268018 DOI

Dřevínek P, Hurych J, Kepka Z, et al. The sensitivity of SARS‐CoV‐2 antigen tests in the view of large‐scale testing. Epidemiol Mikrobiol Imunol. 2021. Summer;70(3):156‐160. PubMed

CDC . Interim guidelines for collecting, handling, and testing clinical specimens for COVID‐19 2020. Available from: https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html

Koskinen JM, Antikainen P, Hotakainen K, et al. Clinical validation of automated and rapid mariPOC SARS‐CoV‐2 antigen test. Sci Rep. 2021;11(1):20363. doi: 10.1038/s41598-021-99886-6 PubMed DOI PMC

Core Team R . R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2018. https://www.R-project.org

Zhou Y, Wu Y, Ding L, Huang X, Xiong Y. Point‐of‐care COVID‐19 diagnostics powered by lateral flow assay. Trends Analyt Chem. 2021;145:116452. doi: 10.1016/j.trac.2021.116452 PubMed DOI PMC

La Scola B, Le Bideau M, Andreani J, et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS‐CoV‐2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis. 2020;39(6):1059‐1061. doi: 10.1007/s10096-020-03913-9 PubMed DOI PMC

Bullard J, Dust K, Funk D, et al. Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples. Clin Infect Dis. 2020;71(10):2663‐2666. doi: 10.1093/cid/ciaa638 PubMed DOI PMC

Kant R, Nguyen PT, Blomqvist S, et al. Incidence trends for SARS‐CoV‐2 alpha and beta variants, Finland, spring 2021. Emerg Infect Dis. 2021;27(12):3137‐3141. doi: 10.3201/eid2712.211631 PubMed DOI PMC

Harvey WT, Carabelli AM, Jackson B, et al. SARS‐CoV‐2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021;19(7):409‐424. doi: 10.1038/s41579-021-00573-0 PubMed DOI PMC

Tani‐Sassa C, Iwasaki Y, Ichimura N, et al. Viral loads and profile of the patients infected with SARS‐CoV‐2 Delta, Alpha, or R.1 variants in Tokyo. J Med Virol. 2022;94(4):1707‐1710. doi: 10.1002/jmv.27479 PubMed DOI PMC

Kissler SM, Fauver JR, Mack C, et al. Viral dynamics of SARS‐CoV‐2 variants in vaccinated and unvaccinated persons. N Engl J Med. 2021;385(26):2489‐2491. doi: 10.1056/NEJMc2102507 PubMed DOI PMC

Frederik PL, Laust HM, Denwood Matthew J, et al. SARS‐CoV‐2 Omicron VOC transmission in Danish households. medRxiv. 2021;2021.12.27.21268278. doi: 10.1101/2021.12.27.21268278 DOI

Migueres M, Dimeglio C, Trémeaux P, et al. Influence of immune escape and nasopharyngeal virus load on the spread of SARS‐CoV‐2 Omicron variant. J Infect. 2022;S0163‐4453(22):54‐58. doi: 10.1016/j.jinf.2022.01.036 PubMed DOI PMC